Cyclo Therapeutics Inc. - CYTH Net earnings per one share for the last twelve months

Cyclo Therapeutics Inc. (CYTH) - corporate logo

Cyclo Therapeutics generates revenue by developing cyclodextrin-based drugs for specialized centers and patients with Alzheimer's disease. The company raises capital from investors to cover the costs of final clinical trials. Price action depends on the success of Trappsol Cyclo in treating Niemann-Pick disease. This rolling year-over-year EPS chart visualizes earnings, where the -5.40 metric determines this level.

CYTH: cyclotherapeutics.com Net earnings per share for the last 12 months 02/11/2024 - 02/20/2024

Cyclo Therapeutics - analytical breakdowns and key metrics (CYTH)

Fundamental company valuation:CYTH - Cyclo Therapeutics Inc.
Brand item of Cyclo Therapeutics, Inc

Cyclo Therapeutics (CYTH) is integrating ESG standards into the synthesis of cyclodextrin-based drugs to minimize laboratory waste. The percentage change in earnings per share over the last four quarters defines the calculation logic of this ratio. This metric allows for an assessment of capital management efficiency and the actual speed of business scaling. It is critical for investors to compare these rates with industry benchmarks to avoid overpaying for the asset. An analysis of net income per share growth YoY ttm clearly reveals deviations from the market trend.

Competitor analysis

Earnings per one share for the last 12 months VRTX|ALNY: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Insmed Inc (INSM)|UTHR (United Therapeutics Corporation) - Net earnings per share (EPS TTM)|Earnings per share for the last 12 months BMRN (BioMarin)|Net earnings per share for the last 12 months BBIO (BridgeBio)|BGM: Earnings per one share for the last 12 months|Earnings per share for the last twelve months Cogent Biosciences, Inc. COGT|XERS (Xeris Biopharma Inc) - Earnings per one share for the last 12 months|Keros Therapeutics - Net earnings per share (EPS TTM)|Earnings per share for the trailing year ARCT (Arcturus Therapeutics)|ETON: Net earnings per share (EPS TTM)|Kamada Ltd (KMDA) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months Fulcrum Tx|ABEO: Earnings per share for the trailing year|Earnings per share for the last twelve months Mereo BioPharma Group (MREO)|Net earnings per share (EPS TTM) protalix.com (PLX)|Net earnings per share (EPS TTM) PLRX (Pliant Therapeutics Inc)|Net earnings per share (EPS TTM) Applied Therapeutics APLT|RNTX - Earnings per share for the last twelve months|Net earnings per share for the trailing year gelteq.com (GELS)|AYTU (aytubio.com) - Net earnings per share for the last 12 months|Chemomab Therapeutics Ltd - Earnings per share for the trailing year|Net earnings per share for the last 12 months SRXH|Earnings per share for the last twelve months PLRZ|Net earnings per share (EPS TTM) AEZS|INZY: Earnings per one share for the last 12 months|Earnings per share for the last twelve months Reneo Pharmaceuticals Inc. RPHM|Net earnings per share for the last four quarters COSCIENS Biopharma Inc. (CSCI)